This inventor holds 1 USPTO granted patent. Top assignees: Howard Hughes Medical Institute, New England Medical Center Hospitals. Inc., Somatix Therapy Corporation. Active years: 1997.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 140 
1 out of 97 
1 out of 2 
Years Active: 1997
Title: The Innovative Mind of Allan D. Callow
Introduction: Allan D. Callow, an accomplished inventor from St. Louis, MO, has made significant contributions to the field of genetic modification, particularly in the realm of endothelial cells. His innovative work seeks to improve medical processes and treatments for individuals through advanced genetic techniques.
Latest Patents: Allan D. Callow holds a patent focused on the genetic modification of endothelial cells. This patent describes endothelial cells that are transduced with genetic material encoding a polypeptide or protein of interest, along with a selectable marker. The methods for producing and utilizing these transduced endothelial cells are also disclosed. The primary applications of this innovation include enhancing the performance of vascular grafts and facilitating the delivery of various encoded elements such as enzymes, hormones, receptors, or drugs to individuals.
Career Highlights: Throughout his career, Allan has worked with renowned organizations that underscore his expertise in the biomedical domain. Notable companies he has been associated with include Somatix Therapy Corporation and the Whitehead Institute for Biomedical Research. His efforts have played an essential role in advancing research and therapeutic applications in biotechnology.
Collaborations: Allan D. Callow has collaborated with prominent figures in science and research, including Richard C. Mulligan and Lawrence K. Cohen. These collaborations have enriched his research experience and contributed greatly to the advancements in genetic engineering and related fields.
Conclusion: Allan D. Callow exemplifies the spirit of innovation in the scientific community. His work, particularly in the genetic modification of endothelial cells, holds promise for future medical advancements, ultimately benefiting the healthcare sector and improving patient outcomes. With a steadfast commitment to research and collaboration, he continues to pave the way for groundbreaking developments in biotechnology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile